Anti-TNF dose can be reduced in PsA and axSpA
Sign Up to like & getrecommendations! Published in 2021 at "Nature Reviews Rheumatology"
DOI: 10.1038/s41584-021-00714-y
Abstract: Results from a retrospective cohort study suggest that use of a disease activityguided dose optimization (DAGDO) strategy to taper TNF inhibitor therapy is safe and effective in patients with psoriatic arthritis (PsA) or axial spondyloarthritis… read more here.
Keywords: tnf; dose reduced; period; anti tnf ... See more keywords